SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature
Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Maria Ximena Cardona-Blanco, Victor Leal-Martínez, Emilio Abuabara-Franco, Nehomar Pajaro-Galvis*, Jose Cabrales, José Correa, Manuel Cueto, Amable Duran, Alejandro Castellanos, Javier Enamorado, José Bohórquez, Isabella Uparella, Julio Zuñiga, Abraham Chagui, Alfonso Ramos and Luis Lara
Jorge Rico-Fontalvo,Rodrigo Daza-Arnedo,Maria Ximena Cardona-Blanco,Victor Leal-Martínez,Emilio Abuabara-Franco,Nehomar Pajaro-Galvis*,Jose Cabrales,José Correa,Manuel Cueto,Amable Duran,Alejandro Castellanos,Javier Enamorado,José Bohórquez,Isabella Uparella,Julio Zuñiga,Abraham Chagui,Alfonso Ramos,Luis Lara. SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature. J Clini Nephrol. 2020: doi: 10.29328/journal.jcn.1001058; 4: 044-055